Skip to main content

Advertisement

SpringerLink
Log in

Comment on “Rebound hypercalcemia post-denosumab cessation in metastatic breast cancer”: Waxing-Waning Serum Calcium following Denosumab use in a patient with Polyostotic Paget’s Disease of Bone

  • Letter to the Editor
  • Published:
Osteoporosis International Aims and scope Submit manuscript

The Original Article was published on 14 March 2022

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data availability

Not applicable.

Code availability

Not applicable.

References

  1. Wang R, Renouf DA (2022) Rebound hypercalcemia post-denosumab cessation in metastatic breast cancer. Osteoporos Int 33:1625–1629. https://doi.org/10.1007/s00198-022-06369-z

    Article  CAS  PubMed  Google Scholar 

  2. Whitson HE, Lobaugh B, Lyles KW (2006) Severe hypocalcemia following bisphosphonate treatment in a patient with Paget’s disease of bone. Bone 39:954–958. https://doi.org/10.1016/j.bone.2006.04.032

    Article  CAS  PubMed  Google Scholar 

  3. Bannister P, Roberts M, Sheridan P (1986) Recurrent hypercalcaemia in a young man with mono-ostotic Paget’s disease. Postgrad Med J 62:481–483. https://doi.org/10.1136/pgmj.62.728.481

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India

    Rimesh Pal & Sanjay Kumar Bhadada

Authors
  1. Rimesh Pal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sanjay Kumar Bhadada
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sanjay Kumar Bhadada.

Ethics declarations

Conflicts of interest

None.

Ethics approval

Not applicable.

Consent to participate

Written informed consent obtained from the patient.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pal, R., Bhadada, S.K. Comment on “Rebound hypercalcemia post-denosumab cessation in metastatic breast cancer”: Waxing-Waning Serum Calcium following Denosumab use in a patient with Polyostotic Paget’s Disease of Bone. Osteoporos Int 33, 2227–2228 (2022). https://doi.org/10.1007/s00198-022-06443-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-022-06443-6

Search

Navigation